Literature DB >> 16009099

[Analysis of literature on therapeutic methods and medicines of traditional Chinese medicine for primary liver cancer].

Qing Liu1, Yan-Bo Zhang, Chuan-Hong Ma, Xiao-Qiang Yue, Chang-Quan Ling.   

Abstract

OBJECTIVE: To find out the rules of therapeutic methods, formulas and medicines of traditional Chinese medicine (TCM) for primary liver cancer (PLC).
METHODS: The frequencies of treatments and medicines of TCM in 978 pieces of documents concerning PLC were analyzed.
RESULTS: Among the 165 therapeutic methods, 277 formulas and 459 kinds of herbs, the methods for activating blood circulation, the formulas for regulating qi-flowing and the herbs for invigorating qi are the most commonly used.
CONCLUSION: Therapeutic methods such as invigorating qi, regulating qi-flowing and activating blood circulation are the main choices for PLC, and the methods such as clearing heat, removing dampness and nourishing yin are used as supplements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009099     DOI: 10.3736/jcim20050403

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  6 in total

1.  Liver Yin deficiency tonifying herbal extract induces apoptosis and cell senescence in Bel-7402 human hepatocarcinoma cells.

Authors:  Bing Hu; Hong-Mei An; Ke-Ping Shen; Ling Xu; Qin DU; Shan Deng; Yang Wu
Journal:  Exp Ther Med       Date:  2011-10-12       Impact factor: 2.447

2.  Expression of phosphatase and tensin homolog deleted on chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction.

Authors:  Li-Rong Yin; Ze-Xiong Chen; Shi-Jun Zhang; Bao-Guo Sun; Yong-Dong Liu; Hong-Zhong Huang
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

3.  Therapeutic applications of herbal medicines for cancer patients.

Authors:  Shu-Yi Yin; Wen-Chi Wei; Feng-Yin Jian; Ning-Sun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-11       Impact factor: 2.629

4.  Study on TCM Syndrome Differentiation of Primary Liver Cancer Based on the Analysis of Latent Structural Model.

Authors:  Zhan Gu; Xiuzhong Qi; Xiaofeng Zhai; Qingbo Lang; Jianying Lu; Changping Ma; Long Liu; Xiaoqiang Yue
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

5.  Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.

Authors:  Chin-Tsung Ting; Chian-Jue Kuo; Hsiao-Yun Hu; Ya-Ling Lee; Tung-Hu Tsai
Journal:  BMC Complement Altern Med       Date:  2017-02-20       Impact factor: 3.659

Review 6.  Concurrent administration of anticancer chemotherapy drug and herbal medicine on the perspective of pharmacokinetics.

Authors:  Yung-Yi Cheng; Chen-Hsi Hsieh; Tung-Hu Tsai
Journal:  J Food Drug Anal       Date:  2018-02-03       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.